Navigation Links
Researchers find less invasive, highly accurate methods
Date:2/5/2008

n be treated with potentially curative surgery to remove lung tumors, and chemotherapy and radiation are used for patients whose cancer has spread. Staging of cancer is the process by which doctors determine whether a cancer has spread to other sites such as lymph nodes or other organs, and thus which is the most appropriate treatment.

Shortcomings in each method of staging

The traditional staging technique is to first perform a CAT scan of the lungs to find enlarged lymph nodes. PET scans are also used to determine if a cancer has spread, but both CT and PET have limits, Dr. Wallace says. They can only determine if a lymph node is enlarged or has a high metabolism; features which suggest, but do not prove that cancer is present. Most doctors, including the American College of Chest Physicians, now recommend that CT and PET scans be confirmed with a biopsy of the lymph nodes.

Traditionally, such a biopsy could only be done surgically by inserting a rigid steel scope into the chest through a surgical opening above the breast bone. The scope is maneuvered to lymph nodes of interest and a small piece of tissue is taken to look for signs of cancer. This procedure, known as a mediastinoscopy, can only access lymph nodes on the front or sides of the lungs, Dr. Wallace says. Studies summarized by the American College of Chest Physicians have shown it is approximately 78 percent sensitive that is, of all patients whose lung cancer has spread to lymph nodes, this technique can pick up, at most, 78 percent of them, he says. Another limitation of mediastinoscopy is the need for general anesthesia, and the small but real risk of major complications, Dr. Wallace says.

Most lung cancer staging still is done today by mediastinoscopy, but several less-invasive techniques are also now being used. The most common is transbronchial needle aspiration (TBNA), in which a physician places a bronchoscope into the trachea and based on a CT scan,
'/>"/>

Contact: Paul Scotti
scotti.paul@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. MSU researchers make new discoveries on what does and doesnt affect immune system
2. Researchers query FDA about updating requirements for drug approval
3. MITs McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia
4. U of M researchers discover a pathway to turn off immune system cells
5. Oregon researchers find trigger gene for muscle development
6. Researchers uncover more about how poxviruses evade the immune system
7. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
8. Penn researchers discover new target for preventing and treating flu
9. Researchers investigate links between prostate, cadmium, zinc
10. New nanotube findings by Stanford researchers give boost to potential biomedical applications
11. Researchers Map Paths Governing Neuron Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...lue Cross Blue Shield of Michigan,provided more t... information,today to Michigan Attorney General M...tion about Michigan,s individual health insurance ...gan,s individual health insurance market,and esca...te,s last-resort,insurance carrier, in its indivi...
(Date:12/1/2008)...ngs may help improve treatment for psychiatric pro...s) -- Children with lower IQ have an increased ris...ized anxiety disorder and other psychiatric proble...hree decades shows. , Lower childhood IQ was al...anxiety, as well as an increased risk of having tw...
(Date:12/1/2008)...n Board of Medical Specialties (ABMS), the pre-emi...ian specialists in the United States, has appointe...;s new chief operating officer. Her tenure begins ...(Business Wire EON) December 1, 2008 -- Jung has ...s industries including nonprofit, consulting and f...
(Date:12/1/2008)...amera used during molecular breast imaging (MBI) c... 2 cm in size, according to a study performed at t...fifty patients who had suspicious lesions smaller ...cular breast imaging. "There were 128 cancers conf...ka, MD, lead author of the study. "The sensitivity...
Breaking Medicine News(10 mins):Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 3Health News:Low Childhood IQ Tied to Risk of Later Mental Disorders 2Health News: ABMS Appoints Margaret Jung As New COO 2
...ncer campaigners and fund raisers are taking part ...About 7999 people are participating// in the walk ...y are going topless wearing decorated bras, to try... cancer and the Maggie’s Centre. They will start t...
...ed research has given hopes that researchers will ...ir cells in the ears of humans challenged by deafn...detecting vibrations, which is then translated by ...ese hairs could not be replaced and this resulted ...
...rs have stated that there are certain added effect...ll known, but very threatening//. It was explained...is an overwhelming effects on the body that could ... many patients immobile or unable to function norm...
...ealth ministers meetings to consider the rising he...worldwide over the past two days have helped// to ...y of the regional meeting saw the attempts for dev...outheast Asian regional cooperation during the ASE...
Other Medicine News:Health News:Rheumatoid Arthritis Can Manifest In Various Unknown Risks 2Health News:Rheumatoid Arthritis Can Manifest In Various Unknown Risks 3Health News:Rheumatoid Arthritis Can Manifest In Various Unknown Risks 4Health News:Regional Cooperation Promoted in Southeast Asia 2
(Date:12/1/2008)...te Ltd today announced the initiation of a Phase 1...ctive JAK2 inhibitor, in leading medical centers i...yelofibrosis (CIMF). , , The trial is desi...1518 in patients with CIMF and is expected to enro...y will assess the safety profile and evaluate the ...
(Date:12/1/2008)...e announced today that a,comparative study conduc...,discomfort associated with blood glucose testing ... and lancing devices were deemed least painful. ,...HEK Aviva and ACCU-CHEK Compact,Plus blood glucos...ACCU-CHEK,Softclix and ACCU-CHEK Softclix Plus la...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)...two-way switch that, if turned off, causes lymphat...ey lose their identity and become more like blood ...1 Scientists at St. Ju...at a certain differentiated cell type is so ready ...nt expression of a gene called Prox1 to dissuade...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Guided Surgery Technology Gaining Popularity in the Dental Implant Market 5125 1Guided Surgery Technology Gaining Popularity in the Dental Implant Market 5125 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5122 1American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5122 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5122 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5122 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5122 5PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade 28TM 29 for Obstetric and Gynecologic Surgery 1987 1PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade 28TM 29 for Obstetric and Gynecologic Surgery 1987 2PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade 28TM 29 for Obstetric and Gynecologic Surgery 1987 3PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade 28TM 29 for Obstetric and Gynecologic Surgery 1987 4Alseres Pharmaceuticals Enters Agreement to Amend Cethrin 28R 29 License to Lower Milestone Payments and Royalty Rates 1984 1Alseres Pharmaceuticals Enters Agreement to Amend Cethrin 28R 29 License to Lower Milestone Payments and Royalty Rates 1984 2Alseres Pharmaceuticals Enters Agreement to Amend Cethrin 28R 29 License to Lower Milestone Payments and Royalty Rates 1984 3Alseres Pharmaceuticals Enters Agreement to Amend Cethrin 28R 29 License to Lower Milestone Payments and Royalty Rates 1984 4
..., Calif.--(BUSINESS WIRE)--Mar 14, 2007 - Research...say they are puzzled by,findings from their new st...ously showed promise in treating a behavioral diso... a sustained benefit,for the patients who took it....ribed,antidepressant sold under the brand name Lex...
...N, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarmi...of CANCER (a peer-reviewed,journal of the American...taking the standard five-year regimen of the hormo...continue therapy early.(1), According to the autho...or issue that may negatively affect treatment effi...
Other Medicine Technology:Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: